Shots: The company plan to initiate a pivotal P-IIIa program to assess the efficacy and safety of oral semaglutide (50mg) vs PBO in ~1000 people with obesity or overweight with […]readmore
Tags : Oral Semaglutide
Shots: The PIONEER 6 study results involve assessing oral Semaglutide vs PBO in 3,183 patients with type 2 diabetes at high risk of cardiovascular events The PIONEER 6 study results: […]readmore
Shots: The P-IIIa PIONEER 9 trial involves assessing of Oral Semaglutide (3, 7,14 mg, qd) vs Victoza (0.9 mg liraglutide) vs PBO in 243 Japanese adults in ratio (1:1:1:1:1) with […]readmore